Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments

Pere Gascón, Matti Aapro, Heinz Ludwig, Nadia Rosencher, M. Boccadoro, Matthew Turner, Karen MacDonald, Michael Muenzberg, Ivo Abraham

Research output: Contribution to journal › Comment/debate › peer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments'. Together they form a unique fingerprint.

Medicine & Life Sciences